Summary of Key Information:
Reporting Period (Quarter/Year): Quarter and Financial Year ended March 31, 2026
Nature of Filing / Announcement: Outcome of Board Meeting pursuant to Regulation 30, 33, and 52 of SEBI LODR Regulations
Date of Board Meeting / Approval: May 22, 2026 (Meeting held from 03:30 P.M. IST to 07:00 P.M. IST)
Audit Opinion: Unmodified opinion
Auditor’s Comment: Statutory Auditors, M/s. Deloitte Haskins & Sells LLP, issued an Audit Report with an unmodified opinion on the Audited Financial Results (Standalone and Consolidated).
Key Financial Highlights [₹ in million]
Standalone Results:
Revenue from Operations:
- Q4 FY26: ₹10,440.50 (vs Q4 FY25: ₹9,190.27)
- FY26: ₹39,751.41 (vs FY25: Not provided in comparable format)
Total Income:
- Q4 FY26: ₹11,711.09
- FY26: ₹41,515.75
EBITDA:
- Q4 FY26: ₹3,536.74
- FY26: ₹10,158.82
Net Profit:
- Q4 FY26: ₹2,021.25
- FY26: ₹5,031.13
EPS (₹):
- Q4 FY26 (Basic & Diluted): 9.95 (not annualized)
- FY26 (Basic & Diluted): 24.77 (annualized)
Other Equity (Reserves): ₹23,930.71 (as of March 31, 2026)
Cash and Cash Equivalents: ₹1,802.91 (as of March 31, 2026)
Debt:
- Non-current borrowings: ₹17,377.47
- Lease liabilities (Non-current): ₹1,174.60
- Current maturities of long-term borrowings: Included in current financial liabilities
- Total borrowings (incl. lease): ₹18,552.07 (Non-current) + current portion
Consolidated Results:
Revenue from Operations:
- Q4 FY26: ₹25,938.06
- FY26: ₹78,960.35
Total Income:
- Q4 FY26: ₹26,230.35
- FY26: ₹79,962.54
EBITDA:
- Q4 FY26: ₹5,392.12
- FY26: ₹17,168.91
Net Profit (Attributable to owners):
- Q4 FY26: ₹2,238.78
- FY26: ₹8,055.99
EPS (₹) - Continuing Operations:
- Q4 FY26 (Basic & Diluted): 11.22 (not annualized)
- FY26 (Basic & Diluted): 39.89 (annualized)
Other Equity (Reserves): ₹43,328.97 (as of March 31, 2026)
Cash and Cash Equivalents: ₹7,605.73 (net of bank overdraft; gross ₹7,700.67 as of March 31, 2026)
Debt (Consolidated):
- Non-current borrowings: ₹46,671.82
- Lease liabilities (Non-current): ₹8,496.20
- Current borrowings: ₹1,988.68
- Current lease liabilities: ₹1,418.25
Segment-wise Performance [₹ in million]
The Group's operating segments are 'Medical and Healthcare Related Services' and 'Others (Insurance Segment)'.
Segment Revenue (FY26 Audited):
- Medical and healthcare related services: ₹76,886.87
- Others (Insurance): ₹3,856.50
- Less: Inter-segment revenue: (₹405.65)
- Total revenue from operations: ₹80,337.72
Segment Result (FY26 Audited):
- Medical and healthcare related services: ₹12,386.22
- Others (Insurance): (₹1,241.90)
Corporate Actions:
Dividend: The Board has recommended a final dividend of ₹4.50 per equity share (face value ₹10 each) for FY26, subject to shareholder approval at the AGM. The record date for determining entitlement is Friday, July 17, 2026.
Capital Raising: The Board resolved to seek enabling approval from shareholders via a Special Resolution for issuing Debt Securities (including NCDs) for an amount not exceeding ₹1,500 Crores in a financial year, in one or more series/tranches, on a private placement basis.
Other Significant Information:
26th Annual General Meeting (AGM) will be held on Friday, August 14, 2026, via Video Conferencing (VC)/Other Audio-Visual Means (OAVM).
Entities in Consolidation: The consolidated results include 24 entities (subsidiaries, an associate, and a joint venture), as listed in Annexure I of the auditor's report.
Exceptional Items: As mentioned above, related to the impact of Labour Codes and loss on disposal of a discontinued operation.